SCHEMBL9928637

SCHEMBL9928637

Cc1ccc(-c2ccc3ccc4c(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)ccc5ccc2c3c54)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
ATM Q13315 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 4/20 0.33
RXFP1 Q9HBX9 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
AKR1C4 P17516 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
AKR1C1 Q04828 1/20 0.33
MAPK10 P53779 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
KMT2A Q03164 2/20 0.32
TP53 P04637 1/20 0.31
HDAC4 P56524 1/20 0.31
THRB P10828 1/20 0.31
COMT P21964 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920753 0.93 KDM4E (0.34) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL13872311 0.90 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL9920625 0.90 L3MBTL1 (0.43) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL9921080 0.90 L3MBTL1 (0.43) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL9928756 0.89 L3MBTL1 (0.41) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL13872357 0.89 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL9921051 0.89 L3MBTL1 (0.40) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL9921040 0.88 L3MBTL1 (0.36) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL13872153 0.88 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1RXFP1
SCHEMBL9920881 0.88 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-8502201-B2 Light-emitting element TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20110121268-A1 LIGHT-EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2011-05-26 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 KDM4E 2433/4885ATM 1983/4885L3MBTL1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.